Insider · CIK 0001742858
Jonathan Lanfear
Files at MTEM (Molecular Templates, Inc.). First filing -, latest -.
In brief
Jonathan Lanfear files SEC Form 4 as director at MTEM (Molecular Templates, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jonathan Lanfear has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 27, 2023 | MTEM Molecular Templates, Inc. | AGrant or award Stock Option (right to buy)derivative | +1,000 | $0.00 | $0 | 1,000 | Oct 31, 2023 |
Questions about Jonathan Lanfear
Answered from the filings on this page, as of the latest one.
Is Jonathan Lanfear buying or selling?
Jonathan Lanfear has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jonathan Lanfear's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Lanfear has 0.
Where does Jonathan Lanfear file Form 4?
Jonathan Lanfear has filed Form 4 at MTEM (Molecular Templates, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.